Are women losing out on pharmacy’s top jobs?

  The majority of pharmacy’s workforce are women, so why do men continue to secure the top jobs? I’m writing this on a train returning home...

NHS’s prophecy is threatened as the game changes

  This year is the 70th anniversary of the NHS; that embodiment of the Good Samaritan parable admirably rooted in the Christian socialism of 1940s...

What’s the future for healthcare data?

  We’re just getting used to it, but will healthcare data become federated in the future? An overwhelming trend in 2018 will be increasing restrictions around...

Driving innovative relationships in the evolving NHS

THE SITUATION Environmental change: Healthcare delivery’s metamorphosis Last month, in the January issue of Pf Magazine, I discussed evolving accountable care systems and organisations. The key...

Martin Moth on digital’s answer to our weight problem

Britain has a weight problem that can only be solved with honest interaction and digital functionality. Speak your weight machines – where have they gone?...

NHS commissioning landscape about to become treacherous

Commission accomplished? A landscape that once stood on the precipice of functionality has since become a treacherous maze. I have a useful ‘pivot table’ listing the...

Customer facing effectiveness: Time for a new approach?

The era of customer centricity has arrived. But what’s the best way for pharma to engage? Words by Samir Paul One of the areas we have...

What does the Life Sciences Sector Deal really mean?

  Big deal The UK has a huge amount to offer the life sciences sector. It combines globally renowned scientific research bases with a...

Cold comfort: The Christmas period can be isolating for many

    Cold comfort The festive season can be a stressful time for most of us and it’s even harder for those struggling with...

Latest articles

Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Pf Award Winners

Pf Award Winners on the positive patient outcomes that come from working together

The winners of the Joint Working Pf Award 2018, Senior Coloplast Care Nurse Ruth Christer and NHS Partnership Manager, Coloplast, Jonathan Walker, on the...
Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...

Popular articles

Brain scan image: Detecting and managing atrial fibrillation

Detecting and managing atrial fibrillation

The ‘Podiatry and Atrial Fibrillation – Save a life, stop a stroke’ webinar was created to improve the detection and management of atrial fibrillation,...
Samsung Bioepis Announces Three-year Follow-up Data for Biosimilar ONTRUZANT® (trastuzumab) in Early or Locally Advanced HER2-positive Breast Cancer

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab)

Samsung Bioepis announces three-year follow-up data for biosimilar ONTRUZANT® (trastuzumab) in early or locally advanced HER2-positive breast cancer. Samsung Bioepis has announced the findings of...
The future of genomics

The future of genomics and precision medicine

How is the use of genomics data enhancing our medical understanding and what does this mean for the future of precision medicine? Genomics is one of...
Investigational therapy has potential to become first oral GLP-1 receptor agonist for those living with type 2 diabetes

Novo Nordisk presents oral semaglitude data at ENDO

Oral semaglutide 7 mg and 14 mg doses showed superior reductions in blood sugar and weight compared to sitagliptin at 26 weeks in data...
Image of graduates: skills shortage in life sciences

Addressing the skills shortage in life sciences

How can collaboration help to fill the skills shortage gap to ensure that the UK can compete in the global future of life sciences? The...